Abstract
Glaucoma is one of important causes of irreversible vision loss and remains a global health problem. The pathophysiology of glaucoma involves several etiopathogenic mechanisms that have generated the development of topical and surgical treatments with an effect in slowing the progression of the disease. In the last decade, it was concluded that glaucomatous optic neuropathy is a disease with neurodegenerative elements, the destructive neuronal lesions being located not only in the structure of the retina, but also at the central visual pathways. This review highlights the experimental and clinical data obtained so far, which underline the neurodegenerative character of the glaucomatous disease and the elements of neuroconnectivity developed during the evolution of the disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
